Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme

This study has been terminated.
(Loss of funding)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
UNC Lineberger Comprehensive Cancer Center Identifier:
First received: September 23, 2005
Last updated: March 5, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)